Skip to content
Screener

McKesson MCK Medical-Surgical Solutions — Subtotal

Similar metrics at other companies

ESAB logo
ESABAmericas: — Subtotal
$10.37M—
ESAB logo
ESABEMEA and APAC Segment — Subtotal
$35K—
Medtronic logo
MDTMedical Surgical — Depreciation
$56M+5.7%
Medtronic logo
MDTMedical Surgical — Net Sales
$2.39B+8.0%
Medtronic logo
MDTMedical Surgical — Other segment items
$5M+25.0%
Medline, Inc. logo
MDLNSurgical Solutions — Net Sales
$1.64B+8.7%

Other financials

Income statement

See full
Revenue$105.38B+7.7%
Gross profit$3.7B+12.4%
Operating income$1.3B+27.3%
Net income$614.0M-21.7%
EPS (diluted)$5.15-17.6%

Balance sheet

See full
Cash & equivalents$5.3B+95.9%
Total debt$13.0B+15.7%
Total equity-$4.2B-116%
Total assets$88.3B+8.6%

Cash flow

See full
Operating cash flow-$220.0M+76.0%
CapEx$112.0M+0.9%
Free cash flow-$332.0M+67.7%

Valuation

See full
Market cap$102.7B+16.8%
Enterprise value$110.42B+14.5%
P/E22.4×-5.4×
P/S0.3×0.0×

Profitability

See full
Gross margin3.6%+0.1pp
Operating margin1.6%+0.4pp
Net margin1.1%+0.3pp
FCF margin1.6%0.0pp

Returns & leverage

See full
Return on equity36%—
Debt / equity2×—
Current ratio0.9×0.0×

Where this comes from

Reported directly by McKesson in its filing.

Tagged under the XBRL concept mck:GrossProfitNetOfExpensesIncludingOtherIncome.

The source filing: McKesson’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:29 PM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0000927653-26-000234
(In millions)Three Months Ended June 30, 2026Three Months Ended June 30, 2025
North American Pharmaceutical$903$594
Oncology & Multispecialty325212
Prescription Technology Solutions226253
Medical-Surgical Solutions122221
Other—13
Subtotal1,5761,293
Corporate expenses, net (6)(191)(193)
Interest expense(77)(49)

Item 1. Condensed Consolidated Financial Statements.

FAQ

What is McKesson's medical-surgical solutions — subtotal?
McKesson (MCK) reported medical-surgical solutions — subtotal of $122M in Q2 2026.
How has McKesson's medical-surgical solutions — subtotal changed year-over-year?
McKesson's medical-surgical solutions — subtotal decreased by 44.8% year-over-year, from $221M to $122M.
What is the long-term trend for McKesson's medical-surgical solutions — subtotal?
Over 2 years (2024 to 2026), McKesson's medical-surgical solutions — subtotal has grown at a -0.9% compound annual growth rate (CAGR), from $955M to $938M.
What does medical-surgical solutions — subtotal mean?
A calculated subtotal representing the intermediate financial performance of the Medical-Surgical Solutions segment before final adjustments or corporate allocations. This figure provides a clearer view of the segment's operational health before accounting for non-operational or corporate-level items. It is a key metric for evaluating the segment's standalone profitability.

Ask your AI about McKesson's medical-surgical solutions — subtotal.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude